Skip to main content

Stryker Corporation company profile

  • SYK · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$309.64−0.88%Close 13 Nov 2026

About Stryker Corporation

Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology (60% of 2024 revenues), which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery (40% of 2024 revenues), which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.

The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000.

From Wikipedia, shared under CC BY-SA.

Company facts

TickerSYK · NYSE
SectorMedical devices
IndustryHealth Care Equipment
IndexS&P 500
Fiscal year ends31 December
Reporting currencyUSD
CIK310764

Officers and directors

NameRoleShares ownedLatest Form 4
Ronda E. StrykerDirector15.4M · 4%Open-market sale, 6 Nov 2026
Kevin A. LoboChair and CEO · Director1.2M · < 1%Shares withheld for tax, 21 Mar 2026
J. Andrew PierceGroup President246K · < 1%Shares withheld for tax, 21 Mar 2026
Spencer S. StilesPresident and COO243K · < 1%Gift, 1 Jun 2026
Glenn S. BoehnleinVP, Chief Financial Officer196K · < 1%Option exercise, 21 Mar 2025
Viju S. MenonGroup President178K · < 1%Shares withheld for tax, 21 Mar 2026
Preston W. WellsVP, Chief Financial Officer29.1K · < 1%Code J, 24 Sep 2026
Andrew K. SilvernailDirector21.3K · < 1%Grant or award, 6 May 2026
Mary K. BrainerdDirector9.5K · < 1%Grant or award, 6 May 2026
Rajeev SuriDirector5.9K · < 1%Grant or award, 6 May 2026
Lisa M. Skeete TatumDirector3.9K · < 1%Grant or award, 6 May 2026
Sherilyn S. McCoyDirector3.8K · < 1%Grant or award, 6 May 2026
Giovanni Caforio, M.D.Director3.2K · < 1%Grant or award, 6 May 2026
Rachel M. RuggeriDirector679 · < 1%Grant or award, 6 May 2026
Crotty Dylan BramGroup President—Open-market sale, 21 Aug 2026
King DebraSee Remarks—Open-market sale, 18 Aug 2026
Montagnino Kimberly AnnVP, Chief Comm. Officer—Shares withheld for tax, 1 Aug 2026
Fletcher Robert SVP, Chief Legal Officer—Shares withheld for tax, 1 Aug 2026
Fink M KathrynVP, Chief HR Officer—Shares withheld for tax, 1 Aug 2026
Emmanuel P. MacedaDirector—Grant or award, 6 May 2026

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

SYK in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.